Kazia Therapeutics Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 560.00 K | $7.88 M | 100.00% | 17.95% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 08/06/2026 | 414.96 K | $5.84 M | 191.26% | 13.30% |
| BLEICHROEDER LP | 08/13/2026 | 400.00 K | $5.63 M | 0.00% | 12.82% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 396.20 K | $5.58 M | 100.00% | 12.70% |
| DAUNTLESS INVESTMENT GROUP, LLC | 08/13/2026 | 354.21 K | $4.99 M | 343.69% | 11.35% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 345.18 K | $4.86 M | 0.00% | 11.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 251.70 K | $3.54 M | 100.00% | 8.07% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 200.30 K | $2.30 M | 0.15% | 6.42% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 110.78 K | $1.56 M | 100.00% | 3.55% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 101.38 K | $1.43 M | 100.00% | 3.25% |
| UBS GROUP AG | 08/13/2026 | 81.09 K | $1.14 M | 481.96% | 2.60% |
| CITADEL ADVISORS LLC | 09/02/2026 | 76.00 K | $1.07 M | 100.00% | 2.44% |
| J. GOLDMAN & CO LP | 08/14/2026 | 68.49 K | $964.35 K | 100.00% | 2.19% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 61.55 K | $866.62 K | 100.00% | 1.97% |
| JANE STREET GROUP, LLC | 08/14/2026 | 57.14 K | $804.53 K | 100.00% | 1.83% |
| BARCLAYS PLC | 08/14/2026 | 57.00 K | $802.55 K | 137.51% | 1.83% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 50.62 K | $712.67 K | 100.00% | 1.62% |
| COOPERMAN LEON G | 08/14/2026 | 50.00 K | $704.00 K | 100.00% | 1.60% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 07/27/2026 | 47.59 K | $670.00 K | -5.63% | 1.53% |
| MORGAN STANLEY | 08/13/2026 | 46.61 K | $656.21 K | 4,560.60% | 1.49% |
| MARSHALL WACE, LLP | 08/13/2026 | 44.23 K | $622.77 K | 100.00% | 1.42% |
| JANE STREET GROUP, LLC | 08/14/2026 | 36.00 K | $506.88 K | 100.00% | 1.15% |
| XTX TOPCO LTD | 08/14/2026 | 31.19 K | $439.10 K | 100.00% | 1.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 30.60 K | $430.85 K | 100.00% | 0.98% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 30.09 K | $423.67 K | 2,683.53% | 0.96% |
| CITADEL ADVISORS LLC | 09/02/2026 | 28.51 K | $401.41 K | 100.00% | 0.91% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 22.60 K | $318.19 K | 43.49% | 0.72% |
| SEQUOIA FINANCIAL ADVISORS, LLC | 07/17/2026 | 20.00 K | $281.64 K | -66.66% | 0.64% |
| ENGINEERS GATE MANAGER LP | 08/14/2026 | 14.98 K | $210.85 K | 100.00% | 0.48% |
| LAIRD NORTON TRUST COMPANY, LLC | 08/14/2026 | 12.90 K | $181.63 K | 4.03% | 0.41% |
| UNITED BANK | 07/30/2026 | 12.85 K | $180.94 K | 100.00% | 0.41% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 12.70 K | $178.82 K | 0.00% | 0.41% |
| JPMORGAN CHASE & CO | 08/12/2026 | 2.86 K | $41.40 K | 100.00% | 0.09% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 2.00 K | $20.00 K | 100.00% | 0.06% |
| GAMMA INVESTING LLC | 07/07/2026 | 1.93 K | $27.12 K | 22.83% | 0.06% |
| RHUMBLINE ADVISERS | 08/12/2026 | 1.30 K | $18.25 K | -7.56% | 0.04% |
| SRS CAPITAL ADVISORS, INC. | 08/10/2026 | 87 | $1.23 K | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 24 | $338 | 100.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 20 | $282 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 10 | $140 | -99.89% | 0.00% |
| ALLWORTH FINANCIAL LP | 08/11/2026 | 1 | $15 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| FNY INVESTMENT ADVISERS, LLC | 07/08/2026 | 0 | $0 | -100.00% | 0.00% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Kazia Therapeutics Limited institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of Kazia Therapeutics Limited. The most heavily invested institutionals were:
Boxer Capital Management, LLC: 560,000
FLPUTNAM INVESTMENT MANAGEMENT CO: 414,958
Bleichroeder LP: 400,000
Ikarian Capital, LLC: 396,201
Dauntless Investment Group, LLC: 354,208
Stonepine Capital Management, LLC: 345,179
116.63% of Kazia Therapeutics Limited stock is owned by institutional investors.
Institutional investors have bought a total of 3.64 M shares in the last 24 months. This purchase volume represents approximately $29.92 M in transactions.